BOLAJI BANKOLE: Open Payments
NPI 1801133269 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 38 payments from 10 companies in 2025. Trend: 2023 $704 · 2024 $756 · 2025 $835
Food & beverage: $769Education: $66
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 6 | $210 |
| ABBVIE INC. | 6 | $90 |
| Janssen Pharmaceuticals, Inc | 4 | $86 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
| Alkermes, Inc. | 4 | $77 |
| Neurocrine BioSciences, Inc. | 3 | $71 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Vanda Pharmaceuticals Inc. | 1 | $16 |
Products named: UZEDY, VRAYLAR, COBENFY, CAPLYTA, ARISTADA, INGREZZA, INVEGA SUSTENNA, Auvelity.
Industry payments across NY — which companies pay providers there.
